Navigation Links
Novavax CEO to Present at ACUMENBioFin's 9th Annual Healthcare Conference
Date:10/29/2007

ROCKVILLE, Md., Oct. 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) Chief Executive Officer Dr. Rahul Singhvi will present at ACUMENBioFin's 9th Annual Healthcare Conference at 10:55 am Eastern time on November 6, 2007 at the The New York Palace Hotel, New York City, the company announced today.

Dr. Singhvi will provide an overview of the company's strategy, research and development progress and strategic partnerships. A link to an audio webcast of his presentation will be available at 10:55 am Eastern time on November 6, 2007 through the company's website, http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 30 days.

ABOUT NOVAVAX

Novavax Inc. clinical stage company committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. Using the company's proprietary virus-like particle (VLP) and Novasome(R) adjuvant technologies, Novavax is developing vaccines to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. Novavax's particulate vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection at lower doses than current vaccines. With an exclusive portable manufacturing system that allows for rapid mass-production of vaccines, Novavax is uniquely positioned to meet global public health needs. Additional information about Novavax is available at http://www.novavax.com and in the company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show
2. Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
3. Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
4. The Past, Present and Future of HLA Typing
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2020)... ... , ... During a crisis, the platitude “stay strong” is well-intended, but difficult ... and strengthened through hardship. Recent research conducted by PsychTests.com reveals that mentally ... order to stay strong in the face of adversity. It seems that resilience isn’t ...
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... ... lung, and vascular hospital, and an Alliance member of the Cleveland Clinic Heart, ... patients diagnosed with chronic obstructive pulmonary disease (COPD). , COPD is a growing ...
(Date:5/28/2020)... ... May 28, 2020 , ... Reinforcing ... releases its latest white paper, Caring for our Children: A Look at Patient ... practices in pediatric settings and highlights key findings to help organizations achieve their ...
Breaking Medicine Technology:
(Date:5/26/2020)... ... ... Today TRC Companies (“ TRC ”) announced the release of its ... and leaders assess whether their organizations are prepared to move forward as the country ... to assist business leaders evaluate their readiness relative to CDC guidance and provides ideas ...
(Date:5/25/2020)... (PRWEB) , ... May 23, 2020 , ... Winemaker Grant ... moment. We wanted to present something whimsical and delicious in these complicated times,” he ... Wine Blend ($34.99) and 2018 Grenache ($24.99). The Chardonnay and Red Wine Blend are ...
(Date:5/21/2020)... ... May 21, 2020 , ... Summit Medical , an ... over one million FDA-compliant face shields — designed, engineered and manufactured in the ... need for personal protective equipment (PPE) for both front-line health care workers and ...
(Date:5/21/2020)... ... ... A Safe Haven Foundation (ASHF) has been selected as one of 26 nonprofit organizations ... fund was created in March to help nonprofits with their immediate response to COVID-19 ... in hard-hit communities. , “We are humbled and honored to be named a ...
(Date:5/21/2020)... AUSTIN, Texas (PRWEB) , ... May 21, 2020 , ... ... fire departments and hospitals, today announced the findings of its 2020 ESO Fire ... the number of EMS calls versus fire-related calls, first apparatus turnout time and travel ...
Breaking Medicine News(10 mins):